SFL Regulatory Affairs & Scientific Communication GmbH

Tweet this page
<
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 20 Jan 2017
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

150,000€

Financial year: Jan 2015 - Dec 2015

Lobbyists (Full time equivalent)

2 Fte (4)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    SFL Regulatory Affairs & Scientific Communication GmbH   (SFL)

    EU Transparency Register

    31442479070-19 First registered on 02 Jul 2012

    Goals / Remit

    SFL Regulatory Affairs & Scientific Communication Ltd (SFL) is a multi-national team with extensive experience in the pharmaceutical as well as medtech industries.

    SFL’s core competencies are:
    • Regulatory Affairs
    • Public Affairs
    • Legal Affairs
    • Medical Communication

    This enables us to understand and meet clients’ needs through every stage of the product lifecycle. Each team member has a proven track record in specific areas of expertise and an excellent understanding of the interconnectedness of the different stages and functions of the lifecycle of a product.

    Public Affairs Services
    SFL advises organizations on how to engage in the EU debate to shape healthcare policies and regulatory frameworks. Our team has extensive hands-on experience and proven success in contributing to EU healthcare laws and policies. SFL's public affairs team has worked in functions inside the industry as well as in the public sector. Our public affairs services comprise:
    EU political intelligence (monitoring, impact analysis of coming/changing laws and policies, news updates tailored to client needs)
    Engagement strategy (stakeholder mapping, strategic partnerships, working with industry associations, step-by-step plans to address policy and regulatory matters, support with drafting communication materials, coordination of workshops and debates)
    Capacity building (training on Eu institutions and legislative processes, public affairs methods and tools, lobbying codes, advice on internal organizational matters to help clients formulate aligned positions and speak with one voice to regulators and policy-makers)

    SFL supports our clients by offering personalized and comprehensive services which, when combined, provide an integrated solution for products from the bench to the marketplace within one consultancy.
    SFL offers expertise in the following product classes - drugs, medical devices, in vitro diagnostics, combination products, and ATMPs - and in a broad range of therapeutic areas.

    SFL is an associate member of EuropaBio.

    Main EU files targeted

    Medical Devices Regulation - 2012/0266/COD
    In-vitro Diagnostics Regulation - 2012/0267/COD
    Clinical Trials Regulation EU No 536/2014
    Data Protection Regulation - 2012/0011/COD
    EUnetHTA
    European Medicines Agency policy on publication of
    clinical data for medicinal products for human use - EMA/240810/2013
    Horizon 2020
    EU pharmacovigilance system including Regulation No 1235/2010 and Directive 2010/84/EU as integrated in Regulation (EC) No 726/2004 and Directive 2001/83/EC
    EU personalised medicine activities such as Use of '-omics' technologies in the development of personalised medicine SWD(2013) 436 final
    Orphan Drug Regulation EU No 141/2000

    Address

    Head Office
    Schillerstrasse 7
    Basel 4053
    SWITZERLAND
    EU Office
    Square de Meeûs 38/40
    Brussels
    BELGIUM
  • People

    Total lobbyists declared

    4

    Employment timeLobbyists
    75%2
    25%2

    Lobbyists (Full time equivalent)

    2

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Ms Shayesteh Fürst-Ladani (CEO)

    Person with legal responsibility

    Ms Shayesteh Fürst-Ladani (CEO)

  • Categories

    Category

    I - Professional consultancies/law firms/self-employed consultants

    Subcategory

    Professional consultancies

  • Networking

    Affiliation

    SFL is an associate member of EuropaBio

    SFL is a member of Medical Cluster

    SFL is a member of Biovalley Basel - the Life Sciences Network

    SFL is a member of the British-Swiss Chamber of Commerce

    SFL is a member of Rare Disease Action Forum (RDAF)

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2015 - Dec 2015

    Lobbying costs for closed financial year

    150,000€

    Other financial info

    None declared

    Declared lobby clients

    Client Name Amount
    AbbVie 0€ - 9,999€
    Amgen 0€ - 9,999€
    Europabio 50,000€ - 99,999€
    F. Hoffmann-La Roche Ltd 100,000€ - 199,999€
    MSD 0€ - 9,999€
    Novartis 0€ - 9,999€
    Novo Nordisk 0€ - 9,999€
    Pfizer 0€ - 9,999€
  • EU Structures

    Groups (European Commission)

    None

    ACC

    None

    Groups (European Parliament)

    None

    Communication activities

    SFL supports its clients with analysis and strategic communication advice on the dossiers and activities listed under ‘Main EU initiatives, policies and legislative files monitored by your organisation’.

    SFL also supports its clients in the implementation of such advice, e.g. by drafting position papers, articles and educational materials for the purpose of understanding and participating in the debate.

    SFL also did various outreach during 2015 to Brussels stakeholders including members of the European Parliament in the preparation of its own inaugural event in Brussels entitled ‘A common policy vision for the pharma and device field?’ which took place on 3 March 2015.
    Link to event report
    http://www.sfl-services.com/en/news?id=7LBT65Y0-Take-home_messages_from_SFLs_inaugural_event_in_Brussels_A_common_policy_vision_for_the_pharma_and_device_field

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard